| +1.85 / +13.02%|
The 9 analysts offering 12-month price forecasts for Achillion Pharmaceuticals Inc have a median target of 12.00, with a high estimate of 22.00 and a low estimate of 5.00. The median estimate represents a -25.28% decrease from the last price of 16.06.
The current consensus among 11 polled investment analysts is to Buy stock in Achillion Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.